Richard Vosser
Stock Analyst at J.P. Morgan
(3.04)
# 2,616
Out of 4,421 analysts
1201
Total ratings
48.9%
Success rate
1.5%
Average return
Main Sectors:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | $13,154.00 | +21.64% | 30 | Jun 9, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 250.00 | $279.92 | -10.69% | 154 | Jun 8, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €150.00 | $133.05 | +12.74% | 145 | Jun 1, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €50.00 | $37.15 | +34.59% | 142 | May 12, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 135.00 | $118.04 | +14.37% | 118 | May 5, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €95.00 | $73.34 | +29.53% | 162 | May 5, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 325.00 | $319.00 | +1.88% | 191 | May 1, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €295.00 | $217.10 | +35.88% | 73 | Apr 23, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €260.00 | $165.50 | +57.10% | 27 | Apr 23, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | €130.00 | $154.50 | -15.86% | 15 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €950.00 | $764.20 | +24.31% | 3 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1,923.00 | - | 7 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $925 → $1,100 | $877.72 | +25.32% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €230.00 → €300.00 | $249.31 | +20.33% | 19 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 3.50 → CHF 3.00 | $3.12 | -3.85% | 15 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $43.19 | - | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $147.08 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $3.98 | +0.50% | 8 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €250.00 → €260.00 | $173.20 | +50.12% | 17 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 645.00 → CHF 650.00 | $491.60 | n/a | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €3.00 → €3.50 | $1.24 | n/a | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $54 → $39 | $10.56 | n/a | 7 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €43.63 | $50.55 | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 3,000p | $1,451.00 | n/a | 7 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $176 | $45.20 | n/a | 1 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $49.74 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 | $143.11 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $205 → $200 | $28.32 | n/a | 2 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €185.00 | $24.58 | n/a | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 1,150 | $1,614.50 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.27 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $42.38 | n/a | 1 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 | $7.40 | n/a | 1 | Jan 4, 2017 |
AstraZeneca PLC
Jun 9, 2026
Maintained: Buy
Price Target: 16,000p
Current: $13,154.00
Upside: +21.64%
Novo Nordisk A/S
Jun 8, 2026
Maintained: Hold
Price Target: kr 250.00
Current: $279.92
Upside: -10.69%
Merck KGaA
Jun 1, 2026
Maintained: Buy
Price Target: €150.00
Current: $133.05
Upside: +12.74%
Bayer Aktiengesellschaft
May 12, 2026
Maintained: Buy
Price Target: €50.00
Current: $37.15
Upside: +34.59%
Novartis AG
May 5, 2026
Maintained: Buy
Price Target: CHF 135.00
Current: $118.04
Upside: +14.37%
Sanofi
May 5, 2026
Maintained: Hold
Price Target: €95.00
Current: $73.34
Upside: +29.53%
Roche Holding AG
May 1, 2026
Maintained: Hold
Price Target: CHF 325.00
Current: $319.00
Upside: +1.88%
Sartorius Aktiengesellschaft
Apr 23, 2026
Maintained: Buy
Price Target: €295.00
Current: $217.10
Upside: +35.88%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €260.00
Current: $165.50
Upside: +57.10%
Ipsen S.A.
Mar 27, 2026
Maintained: Hold
Price Target: €130.00
Current: $154.50
Upside: -15.86%
Mar 5, 2026
Maintained: Buy
Price Target: €950.00
Current: $764.20
Upside: +24.31%
Dec 23, 2025
Maintained: Sell
Price Target: n/a
Current: $1,923.00
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: $925 → $1,100
Current: $877.72
Upside: +25.32%
Dec 8, 2025
Maintained: Buy
Price Target: €230.00 → €300.00
Current: $249.31
Upside: +20.33%
Dec 8, 2025
Maintained: Hold
Price Target: CHF 3.50 → CHF 3.00
Current: $3.12
Upside: -3.85%
Nov 24, 2025
Maintained: Buy
Price Target: n/a
Current: $43.19
Upside: -
Nov 20, 2025
Maintained: Hold
Price Target: n/a
Current: $147.08
Upside: -
Sep 3, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $3.98
Upside: +0.50%
Jul 22, 2025
Maintained: Buy
Price Target: €250.00 → €260.00
Current: $173.20
Upside: +50.12%
Dec 3, 2024
Maintained: Buy
Price Target: CHF 645.00 → CHF 650.00
Current: $491.60
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: €3.00 → €3.50
Current: $1.24
Upside: n/a
Dec 5, 2023
Maintained: Hold
Price Target: $54 → $39
Current: $10.56
Upside: n/a
Jan 3, 2023
Upgraded: Buy
Price Target: €43.63
Current: $50.55
Upside: n/a
Sep 27, 2021
Maintained: Buy
Price Target: 3,000p
Current: $1,451.00
Upside: n/a
Mar 18, 2021
Maintained: Buy
Price Target: $176
Current: $45.20
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: n/a
Current: $49.74
Upside: n/a
Jul 28, 2020
Maintained: Buy
Price Target: $142
Current: $143.11
Upside: n/a
Mar 2, 2020
Maintained: Hold
Price Target: $205 → $200
Current: $28.32
Upside: n/a
Jan 6, 2020
Downgraded: Hold
Price Target: €185.00
Current: $24.58
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: kr 1,150
Current: $1,614.50
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $25.27
Upside: n/a
Apr 11, 2017
Upgraded: Hold
Price Target: n/a
Current: $42.38
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: $22
Current: $7.40
Upside: n/a